In this study, we provide a new therapeutic strategy and aim to identify a dual functional molecule that simultaneously targets ATG4B and lysosome to inhibit autophagy, potentially serving as promising anti-tumor agents. The gene discussed is ATG4B; the disease is neoplasm.